Strategic Advisory for Every Stage of the Life Sciences Lifecycle
EVOLUTION Life Science Partners provides specialized investment banking and strategic advisory services to biotechnology, pharmaceutical, medical device, molecular diagnostics, and healthcare companies. From early-stage capital formation to global licensing partnerships and complex M&A transactions, we help management teams navigate pivotal business decisions with confidence.
Industries We Serve
Biotechnology
Pharmaceutical
Medical Device
Molecular Diagnostics
Healthcare Services
Digital Health
Specialty Pharma
Licensing & Strategic Partnerships
Whether you’re seeking a commercialization partner, evaluating in-licensing opportunities, or looking to maximize the value of your intellectual property, EVOLUTION provides deep transaction experience across the global life sciences landscape.
Our team has negotiated licensing and partnering agreements involving pharmaceutical companies, biotechnology firms, academic institutions, and international organizations throughout North America, Europe, and Asia.
- Out-licensing
- In-licensing
- Co-development partnerships
- Commercialization partnerships
- Asset divestitures
- Joint ventures
- Technology evaluations
- Partner identification
- Negotiation support
Mergers & Acquisitions
Whether you’re considering selling your company, acquiring strategic assets, or evaluating merger opportunities, our experienced advisors provide guidance throughout every stage of the transaction process.
We believe every engagement deserves senior-level attention regardless of transaction size. Our focus is building long-term relationships rather than simply closing deals.
- Sell-side advisory
- Buy-side advisory
- Strategic alternatives
- Valuation analysis
- Confidential marketing
- Due diligence management
- Negotiation support
- Transaction execution
Capital Raising
Life sciences companies require specialized financing strategies throughout every stage of development. Our extensive network of institutional investors, venture capital firms, crossover funds, family offices, and strategic investors enables us to identify capital partners aligned with your business objectives.
We have experience across public and private financing transactions.
- Venture Capital
- Series B and later rounds
- PIPE Transactions
- Registered Direct Offerings
- Private Placements
- Growth Capital
- Strategic Investments
- Follow-on Financings
Strategic Advisory
Many life sciences companies face strategic challenges long before a financing or acquisition event. Our team works alongside executive leadership to solve operational, financial, and commercial challenges that can significantly impact company value.
Whether you're navigating manufacturing issues, evaluating commercialization pathways, restructuring development priorities, or preparing for future fundraising, we provide experienced guidance based on decades of industry experience.
- Corporate strategy
- Business development
- Manufacturing capacity
- Commercial planning
- Product portfolio strategy
- Investor readiness
- Board advisory
- Growth planning
